AMPK-dependent mechanisms mediate the protective effects of grape pomace extract in obesity-associated chronic renal disease in mice

Obesity-associated kidney disease involves metabolic dysfunction accompanied by lipotoxicity, inflammation, and fibrosis. We previously showed that grape pomace extract (GPE), a polyphenol-rich byproduct of winemaking, exerts renoprotective effects in obese mice; however, the underlying mechanisms remain incompletely understood. This study aims to investigate whether adenosine monophosphate-activated protein kinase (AMPK) mediates the protective effects of dietary GPE supplementation in high-fat diet (HF)-induced obese mice. Male C57BL/6J mice were fed a standard diet (16% calories from fat) or a HF (60% calories from fat) with or without GPE (300 mg per kg body weight per day) for 16 weeks. A subset of animals was treated with compound C (CC), a widely used AMPK inhibitor, during the last 4 weeks. GPE attenuated HF-induced body weight gain, visceral adiposity, dyslipidemia, glucose intolerance, and renal dysfunction, while improving histopathological alterations. Mechanistically, GPE restored renal AMPK phosphorylation, increased autophagy markers (increased LC3-II/LC3-I ratio and Beclin-1 levels) and reduced renal lipid accumulation. In addition, GPE enhanced levels of the mitochondrial biogenesis regulator PGC-1α, while attenuating oxidative stress (Nox4, 4-HNE, and oxidant species production), inflammatory signaling (NF-κB-NLRP3 pathway), and renal fibrosis. Notably, pharmacological AMPK inhibition reversed the GPE effect, leading to worsening of renal injury, autophagy impairment, increased lipid deposition, and exacerbation of fibrotic and inflammatory markers. These findings demonstrate that AMPK activation is a mediator of the metabolic and renoprotective effects of GPE, positioning GPE as a promising functional food ingredient for attenuation of obesity-associated kidney disease.

Authors

Institutions

Publication Details

Journal
Food & Function
Published
2026-11-16
DOI
https://doi.org/10.1039/d6fo03919g
Primary Topic
Chronic Kidney Disease and Diabetes
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

AMPK-dependent mechanisms mediate the protective effects of grape pomace extract in obesity-associated chronic renal disease in mice

Andrea Antoniolli, Valeria E. Cacciamani, Marcela A. Vazquez Prieto, Diahann Jeanette Perdicaro et al.
1 links
Food & Function
Chronic Kidney Disease and Diabetes
article

AMPK-dependent mechanisms mediate the protective effects of grape pomace extract in obesity-associated chronic renal disease in mice

Andrea Antoniolli, Valeria E. Cacciamani, Marcela A. Vazquez Prieto, Diahann Jeanette Perdicaro, Valeria Victoria Costantino, Laila Suhaiman, Andrea F. Gil Lorenzo, Tatiana S. Figueras
article en

Abstract

Obesity-associated kidney disease involves metabolic dysfunction accompanied by lipotoxicity, inflammation, and fibrosis. We previously showed that grape pomace extract (GPE), a polyphenol-rich byproduct of winemaking, exerts renoprotective effects in obese mice; however, the underlying mechanisms remain incompletely understood. This study aims to investigate whether adenosine monophosphate-activated protein kinase (AMPK) mediates the protective effects of dietary GPE supplementation in high-fat diet (HF)-induced obese mice. Male C57BL/6J mice were fed a standard diet (16% calories from fat) or a HF (60% calories from fat) with or without GPE (300 mg per kg body weight per day) for 16 weeks. A subset of animals was treated with compound C (CC), a widely used AMPK inhibitor, during the last 4 weeks. GPE attenuated HF-induced body weight gain, visceral adiposity, dyslipidemia, glucose intolerance, and renal dysfunction, while improving histopathological alterations. Mechanistically, GPE restored renal AMPK phosphorylation, increased autophagy markers (increased LC3-II/LC3-I ratio and Beclin-1 levels) and reduced renal lipid accumulation. In addition, GPE enhanced levels of the mitochondrial biogenesis regulator PGC-1α, while attenuating oxidative stress (Nox4, 4-HNE, and oxidant species production), inflammatory signaling (NF-κB-NLRP3 pathway), and renal fibrosis. Notably, pharmacological AMPK inhibition reversed the GPE effect, leading to worsening of renal injury, autophagy impairment, increased lipid deposition, and exacerbation of fibrotic and inflammatory markers. These findings demonstrate that AMPK activation is a mediator of the metabolic and renoprotective effects of GPE, positioning GPE as a promising functional food ingredient for attenuation of obesity-associated kidney disease.

Food & FunctionVol. 17(22)
Consejo Nacional de Investigaciones Científicas y Técnicas (AR), Universidad Nacional de Cuyo (AR), Instituto de Biología Agrícola de Mendoza (AR), Instituto de Medicina y Biología Experimental de Cuyo (AR)
Secretaría de Investigación, Internacionales y Posgrado, Universidad Nacional de Cuyo
Good health and well-being
Chronic Kidney Disease and Diabetes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon